WeVote
Log In

Bill

Bill

A 6923

Requires health insurance plans to provide coverage for continuous blood glucose monitors for all children

2025 Regular Session Introduced by David Weprin

Requires health insurance plans to cover continuous glucose monitors for all children, reducing out-of-pocket costs and improving pediatric diabetes management.

REFERRED TO INSURANCE
0
WeVote Research Nonpartisan
Bill Summary · A 6923

Summary: Assembly Bill A 6923 (New York)

Overview

  • Bill number: A 6923
  • Title: Requires health insurance plans to provide coverage for continuous blood glucose monitors for all children
  • Sponsor: David Weprin (primary)
  • Status: REFERRED TO INSURANCE
  • Introduced: March 18, 2025
  • Relation: Companion Senate bill S 8592 (listed as companion)

Purpose and intent

A 6923 would mandate health insurance plans to provide coverage for continuous glucose monitors (CGMs) for pediatric patients. The bill aims to improve access to CGMs for children who require them for diabetes management, potentially reducing out-of-pocket costs for families and supporting better long-term health outcomes through more consistent glucose monitoring.

Key provisions (as stated)

  • Requirement: Health insurance plans must cover continuous glucose monitors for all children.
  • Scope details (not specified in available text): The provided information does not list specifics such as which CGM devices are covered, covered components (sensors, transmitters, receivers), prior authorization rules, cap on benefits, co-payments, reimbursement rates, or duration of coverage. The bill’s text would be expected to address these issues, but they are not detailed in the summary available here.

Who would be affected

  • Children: Pediatric patients who rely on CGMs for diabetes management would gain access to coverage.
  • Families/caregivers: Potential reductions in out-of-pocket costs and insurance denial barriers.
  • Health insurers: Would need to align plans to comply with the coverage mandate, potentially adjusting formularies and benefit structures.
  • Health care providers: Likely to see changes in how CGMs are prescribed and reimbursed.

Procedural and timeline aspects

  • Introduced on March 18, 2025 and immediately referred to the Insurance Committee.
  • The listing shows two identical “REFERRED TO INSURANCE” actions on the same date, which appears to be a duplication in the record.
  • Related action: Senate companion bill S 8592 indicates cross-chamber interest in similar provisions.

Additional context

  • This summary reflects the information available: the bill’s main objective, sponsor, status, and the existence of a Senate companion. Detailed fiscal impact, policy specifics (e.g., device scope, duration, cost-sharing), and potential exemptions or transition rules are not provided in the current materials and would be clarified in the bill's full text and any accompanying fiscal notes.

If you’d like, I can incorporate any available amendments or fiscal analyses from committee materials as they become available.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.